Winthrop Family Scholar in ALS Sciences; director, MGH Neurological Clinical Research Institute (NCRI); and chief, Division of ALS and Motor Neuron Diseases, Massachusetts General Hosptial
Clinical Research in ALS, the Potential of CNM-Au8 in the Care Landscape: James Berry, MD, MPH
April 28th 2023The director of the Massachusetts General Hospital ALS Care Center discussed the importance of effective disease-modifying therapies for ALS and the potential of CNM-Au8 in the management of the disease. [WATCH TIME: 2 minutes]
Results of Clinical Trials for CNM-Au8, A Potential ALS Treatment: James Berry, MD, MPH
April 25th 2023The director of the Massachusetts General Hospital ALS Care Center talked about CNM-Au8 treatment across three populations, as well as the HEALEY ALS Platform Trial, at the 2023 AAN annual meeting. [WATCH TIME: 5 minutes]